Urology Research Options

Urology Research Options (URO) is a specialized clinical research organization and site network that functions as the dedicated research division of MidLantic Urology, a member of Solaris Health. The company focuses on conducting Phase 1 through Phase 4 clinical trials across the full spectrum of urological health, with a particular emphasis on urologic oncology and voiding dysfunction. By integrating clinical research into a large-scale private practice environment, URO provides patients with access to emerging therapies and state-of-the-art medical advancements. The organization offers comprehensive site management services, including patient recruitment, regulatory oversight, and high-quality data collection for pharmaceutical and biotech sponsors.